Trichomonas Vaginalis

Trichomoniasis is one of the most common curable sexually transmitted infections in the world, and it spreads quietly. Most people who carry it have no symptoms at all, yet the infection is linked to preterm birth, pelvic inflammatory disease, higher risk of catching HIV, and a higher risk of cervical precancer when combined with high-risk HPV (human papillomavirus).

This test looks directly for the parasite TV (Trichomonas vaginalis) in a vaginal swab using modern molecular technology. It tells you whether the parasite's genetic material is currently present in your vaginal or urogenital tract, with far more accuracy than the older microscope check still used in many clinics.

What This Test Actually Detects

Unlike most lab tests, this one is not measuring something your body produces. It is detecting the parasite's genetic material. The swab is analyzed for the parasite's DNA or RNA using a technique called NAAT (nucleic acid amplification testing). A positive result usually means the organism is living in your vaginal or urogenital tract. One caveat: nucleic acid can persist for up to three to four weeks after successful treatment, so a positive result shortly after antibiotics does not always mean a live, active infection.

Results are reported as positive or negative. There is no clinically meaningful grading by parasite load or severity, and a positive result is treated the same way regardless of how strong the signal is on the lab report.

Why This Matters for Pregnancy and Reproductive Health

A large U.S. study of more than 13,000 pregnant women found that those infected with TV at mid-pregnancy were significantly more likely to have a low birth weight baby, deliver preterm, or both. A systematic review pooling many studies confirmed that TV infection during pregnancy is associated with preterm birth, premature rupture of membranes, and babies born small for their gestational age.

One important nuance: a Cochrane review found that treating asymptomatic TV in pregnancy with metronidazole has not been shown to reduce preterm birth, and may itself be associated with increased preterm delivery in some studies. Routine screening and treatment of asymptomatic pregnant women remains an unsettled question. If you test positive in pregnancy, this is a conversation to have with your obstetric clinician rather than an automatic decision.

The infection has also been linked to pelvic inflammatory disease. In one study of women with clinically suspected pelvic inflammatory disease, TV was present in about 13% and was associated with higher odds of inflammation inside the uterus, infertility, and recurrent pelvic infection.

HIV and Other Sexually Transmitted Infections

A meta-analysis pooling multiple studies found that people infected with TV were about 1.5 times more likely to acquire HIV than people without the infection. TV often travels in company. Co-infection with bacterial vaginosis, chlamydia, gonorrhea, and Mycoplasma genitalium is common, and bacterial vaginosis itself nearly doubles the risk of catching a new TV infection.

If your test is positive, you should assume you may have been exposed to other STIs at the same time and get tested for them, including HIV. Sexual partners need testing and treatment too, or reinfection is likely.

Cervical Cancer Risk in HPV Carriers

A population-based study of more than 310,000 women found that co-infection with TV and high-risk HPV, especially HPV16, was associated with an increased risk of CIN (cervical intraepithelial neoplasia) grades 2 to 3, the precancerous changes that can lead to cervical cancer. The evidence on this link is not uniform: some pooled analyses, including a large study in rural China, have found a decreased risk of high-grade lesions among TV-positive women with high-risk HPV, and not all reviewers consider TV a co-factor for cervical precancer. Most meta-analyses point to an overall association, but the size and consistency of the effect remain debated. If you carry high-risk HPV, knowing whether you also carry TV is one piece of information among several that may inform follow-up.

Mental Health Associations

A nationwide cohort study of nearly 47,000 women in Taiwan found that women with a history of TV infection had a higher risk of developing psychiatric conditions including depression, anxiety, bipolar disorder, schizophrenia, and substance abuse. This finding comes from a single observational study, and the direction of cause is unclear: depression and related conditions may themselves increase the risk of sexually transmitted infection. The mechanism is not understood and the association needs replication in other populations before drawing firm conclusions.

Why Wet Mount and Standard Vaginitis Panels Miss It

The most common test for TV in clinics is still wet mount microscopy, where a clinician looks for moving parasites under a microscope. This method is fast and cheap but misses many infections. Major guideline sources cite sensitivity of roughly 40 to 68% compared to more accurate methods, and even lower in asymptomatic women. NAATs on vaginal swabs detect more than twice as many infections as wet mount or culture alone.

Other vaginitis panels do not always include TV. A negative result on a panel that only screens for yeast and bacterial vaginosis tells you nothing about TV. Even routine STI screening for chlamydia and gonorrhea does not automatically include TV in many labs. If your test does not specifically name Trichomonas vaginalis, you have not been screened for it.

Vaginal Swab vs Urine Testing

A meta-analysis pooling many studies of commercial assays found that vaginal swabs had higher sensitivity than urine for detecting TV, at 98.0% versus 95.1%. Vaginal swabs are now considered the optimal sample type in women. Self-collected vaginal swabs perform as well as clinician-collected swabs for the major NAAT platforms, which makes accurate at-home testing feasible.

How Accurate Is This Test

Modern NAATs on vaginal swabs are extremely accurate. The numbers below give you a sense of how reliable the result is.

What this means for you: a negative result on a modern NAAT vaginal swab is highly reliable, and a positive result is almost certainly real. A negative on wet mount, on the other hand, leaves a meaningful chance of a missed infection. If your only prior testing was a wet mount, you should consider this a more definitive check.

When Results Can Be Misleading

• Recent antibiotic treatment: NAATs detect genetic material, which can persist for three to four weeks after successful treatment even when the organism is no longer viable. A positive test soon after treatment does not necessarily mean treatment failed. Test-of-cure timing matters.
• Self-swab technique: the swab needs to be inserted into the vagina and rotated to collect cells from the vaginal wall. A swab that barely touches the opening can produce a false negative.
• Sampling during heavy menstrual bleeding: heavy blood in the sample may interfere with some assays. If possible, sample outside of heavy flow days.
• Recent intravaginal products: douches, spermicides, or intravaginal medications used in the hours before sampling can alter the local environment. Avoid them for at least 24 hours before collection.

When and How Often to Retest

A single positive or negative result is not always the end of the story. If you test positive and complete treatment, a NAAT-based test-of-cure can be done as early as about three weeks after multidose metronidazole or four weeks after single-dose therapy, once residual nucleic acid has cleared. Separately, the CDC recommends rescreening about three months after treatment to catch reinfection, since reinfection from an untreated partner is common and high retest positive rates have been documented after single-dose treatment.

If you are sexually active with new or multiple partners, an annual screen is reasonable even without symptoms. If you have HIV, more frequent screening is appropriate because of higher prevalence and worse downstream consequences. If you have symptoms (unusual discharge, irritation, burning with urination), test now rather than waiting.

What to Do If Your Result Is Positive

A positive result is treatable and curable. The decision pathway from here typically involves a short course of an antibiotic from the nitroimidazole family (metronidazole, tinidazole, or secnidazole). Beyond treatment itself, a positive result should trigger a wider workup:

• STI co-screening: get tested for chlamydia, gonorrhea, syphilis, HIV, and consider HPV and herpes if not recently done.
• Partner treatment: all current sexual partners need treatment, even if they have no symptoms. Without this, reinfection is likely.
• Test of cure: a NAAT-based test of cure can be done about three to four weeks after finishing treatment to confirm clearance, with a separate rescreen at three months to catch reinfection.
• Pregnancy: if you are pregnant or planning pregnancy, mention the result to your obstetric clinician. The link to preterm birth and low birth weight is real, but the benefit of treating asymptomatic infection in pregnancy is not settled, so the decision is individualized.